MYOM2 and plasma cell myeloma: Disease progression in myeloma is monitored by the measurement of M-protein in blood and urine as well as serum protein electrophoresis, serum and urine immunofixation, SFLC-assay, additional laboratory parameters, imaging and bone marrow aspirate/biopsy.